Journal article
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban
Abstract
BACKGROUND: In the Hokusai VTE Cancer study, the risk of major bleeding was 2.9% higher in the edoxaban group compared with the dalteparin group, mainly due to more gastrointestinal bleedings in patients with gastrointestinal cancer. The identification of risk factors for gastrointestinal bleeding may help to guide the use of DOACs in these patients.
OBJECTIVES: To evaluate risk factors for gastrointestinal bleeding in patients with …
Authors
Bosch FTM; Mulder FI; Huisman MV; Zwicker JI; Di Nisio M; Carrier M; Segers A; Verhamme P; Middeldorp S; Weitz JI
Journal
Journal of Thrombosis and Haemostasis, Vol. 19, No. 12, pp. 3008–3017
Publisher
Elsevier
Publication Date
December 2021
DOI
10.1111/jth.15516
ISSN
1538-7933